Newsletter & Investment Management Portal

Forgot your password?

ImmunoGen, Inc.

IMGN in NASDAQ
Close Price 14.270USD
As of market close: 2015-07-01
Dividend Ex-Date: N/A
Prev Close Price
14.3800
52-Week Range
5.343 - 15.880

Market Cap.
1.23 B
EPS
-0.6620 (As of 2015-03-31)
Sector
Healthcare

Industry
Biotechnology

StockMarks Ratings

IMGN
SMR SMT SMB SMM SMP SML SMV SMO
needle
needle
needle
needle
needle
needle
needle
needle
28 37 75 19 35 50 36 25
Recommendation Quality Business Management Price Liquidity Volatility Outperformance
 
For a summary description of StockMarks ratings click here

Competitor Analysis

IMGN

Published Reports

IMGN
Report Title Date Pages
Is ImmunoGen, Inc. Ready to Takeoff? 2015-04-17 12
Will ImmunoGen, Inc. Deliver Top-Shelf Performance? 2015-01-23 12
Is ImmunoGen, Inc. a Good Long-Term Investment? 2014-10-30 12
Are ImmunoGen, Inc. Long-Term Fundamentals Solid? 2014-07-31 12
Rating update for ImmunoGen, Inc. 2014-07-04 3
Is ImmunoGen, Inc. a Good Long-Term Investment? 2014-05-08 12
Will ImmunoGen, Inc. Deliver Top-Shelf Performance? 2014-02-13 12
Rating update for ImmunoGen, Inc. 2013-12-16 3
Are ImmunoGen, Inc. Long-Term Fundamentals Solid? 2013-11-18 12
Rating update for ImmunoGen, Inc. 2013-10-10 3
Is ImmunoGen, Inc. In Need of A Cure? 2013-08-07 12
Is ImmunoGen, Inc. for Long-Term Investors? 2013-05-15 12
Rating Update for ImmunoGen, Inc. 2013-03-06 3
Can ImmunoGen, Inc. Rebound? 2013-02-01 12
Is ImmunoGen, Inc. a Good Long-Term Investment? 2012-12-21 12
Can ImmunoGen, Inc. Rebound? 2012-09-14 12
Due Diligence Report for ImmunoGen, Inc. 2012-06-11 10
Due Diligence Report for ImmunoGen, Inc. 2012-02-28 10
Due Diligence Report for ImmunoGen, Inc. 2011-11-15 10
Due Diligence Report for ImmunoGen, Inc. 2011-08-09 10
Due Diligence Report for ImmunoGen, Inc. 2011-05-09 10
Due Diligence Report for ImmunoGen, Inc. 2011-02-08 10
Due Diligence Report for ImmunoGen, Inc. 2010-06-15 8
Due Diligence Report for ImmunoGen, Inc. 2010-06-15 8
Due Diligence Report for ImmunoGen, Inc. 2010-03-04 8
Due Diligence Report for ImmunoGen, Inc. 2010-03-04 8
Our reports can be obtained through:

Quality StockMark Index

IMGN